Skip to content

TB Dermatologie

Active
Private limited companyfounded 2025active for 1 yearBraambessenweg 7, 2490 Balen, BelgiumKBO/BCE: BE 1024.494.796
Summary

TB Dermatologie has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4,299 and a net result of -€701. Its solvency ranks better than 14% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 19-06-2025 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.374.967.794 2440 Geel, since 19-06-2025
Financial year end
31 December
Peppol
Reachable since 30-12-2025

Board and ownership

Board

Financial position

89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€7,478
Turnover
≈ €47,000
estimated
Loss
€701
Equity
€4,299
Total assets
€43,630
Employees on 31-12-2025
1
Filed on 11-02-2026, 170 days before the deadline
Score breakdownraises riskEquity €4,299 (9.9% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €43,630Figures for financial year 2025 (filed on 11-02-2026)Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 16% of micro companies in human health (NACE 86)
Financial strength
Weak
Solvency 35
equity 9.9% of total assets
Liquidity 53
short-term debt 29.1% · cash 12.2%
Profitability 29
return on assets -1.6%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 07-2026: 0.1%lowest value 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026highest value 11-2026: 0.1%● unchanged vs 10-2026highest value
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 14% of them on solvency, 27% on liquidity and 5% on profitability.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Seven signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €43,630
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 11-02-2026)
NBB · annual accounts
raises risk · Equity €4,299 (9.9% of total assets)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 20700 sector peers (2025).
NBB · sector comparison
Position among 20700 sector peers
Solvency
better than 14%
← weakest strongest →
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-02-2026, 170 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
170 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Key points

  • Caution: Less equity than 91% of companies in human healthsector median €124,659 · 20,702 companies €4,299 View

Recent changes

  1. · Gazette deed IncorporationStarting capital €5,000 · Appointment: BIENSTMAN Thomas (director) · Permanent representative: BIENSTMAN Thomas
All 2 events

Comparable companies

These companies have the same main activity as TB Dermatologie: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €23,800 and €49,500, founded between 2024 and 2025.

CompanyTotal assetsGross margin
TB Dermatologie Balen€43,630€7,478
THE HT’s CLINIC Waterloo€43,877€9,410
ASCLEPIOS EXPERTISE Namur€49,541€5,734
Dr. Liesl De Graeve Gent€41,535€7,009
Docteur Valérie MARCHAL Sprimont€39,330€10,803
CaroCura Antwerpen€30,928€5,343
T-URG-DB Brasschaat€23,784€6,950
Full comparison

Key facts about TB Dermatologie

What is the company number of TB Dermatologie?
The company number of TB Dermatologie is 1024.494.796. The VAT number is the same number with BE in front: BE 1024.494.796.
Where is TB Dermatologie based?
The registered office is at Braambessenweg 7, 2490 Balen.Company details
What does TB Dermatologie do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of TB Dermatologie?
The legal form of TB Dermatologie is Private limited company (BV).
When was TB Dermatologie founded?
TB Dermatologie was founded on 19-06-2025.
Is TB Dermatologie still active?
Yes, TB Dermatologie is an active enterprise in the KBO register.
How many employees does TB Dermatologie have?
TB Dermatologie had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of TB Dermatologie?
The turnover in financial year 2025 is ≈ €47,000. This figure is estimated from the gross margin of €7,478 and 48 comparable companies (NACE 86). It probably lies between €32,000 and €78,000. It is a rough estimate.
Is TB Dermatologie profitable?
In financial year 2025, TB Dermatologie made a loss of €701.
Where can I find the annual accounts of TB Dermatologie?
TB Dermatologie filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.